Dr. Hung T. Khong MD
Hematologist-Oncologist | Hematology & Oncology
2000 Circle Of Hope Dr Salt Lake City UT, 84112About
Dr. Hung Khong is a hematologist oncologist practicing in Mobile, AL. Dr. Khong specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Pre-existing immunity to tyrosinase-related protein (TRP)-2, a new TRP-2 isoform, and the NY-ESO-1 melanoma antigen in a patient with a dramatic response to immunotherapy.
- The Waardenburg syndrome type 4 gene, SOX10, is a novel tumor-associated antigen
- Natural selection of tumor variants in the generation of "tumor escape" phenotypes.
- Identification of multiple antigens recognized by tumor-infiltrating lymphocytes from a single patient: tumor escape by antigen loss and loss of MHC expression.
- Primary human lymphocytes transduced with NY-ESO-1 antigen-specific TCR genes recognize and kill diverse human tumor cell lines.
- Generating renal cancer-reactive T cells using dendritic cells (DCs) to present autologous tumor.
- Transduction of an HLA-DP4-restricted NY-ESO-1-specific TCR into primary human CD4+ lymphocytes.
- Immunotherapy of melanoma: a critical review of current concepts and future strategies.
- Activated CD4+ T cells dramatically enhance chemotherapeutic tumor responses in vitro and in vivo.
- Mitf-Mdel, a novel melanocyte/melanoma-specific isoform of microphthalmia-associated transcription factor-M, as a candidate biomarker for melanoma.
- Activated CD4+ T cells enhance radiation effect through the cooperation of interferon-gamma and TNF-alpha.
- miR-125b functions as a key mediator for snail-induced stem cell propagation and chemoresistance.
- A phase I study of intratumoral ipilimumab and interleukin-2 in patients with advanced melanoma.
- miR-125b regulates differentiation and metabolic reprogramming of T cell acute lymphoblastic leukemia by directly targeting A20.
- Demethylating Agents in the Treatment of Cancer.
Clinical Trials
Dr. Hung T. Khong MD's Practice location
Dr. Hung T. Khong MD's reviews
Write ReviewPatient Experience with Dr. Khong
Recommended Articles
- How Immunotherapy Makes a Real Difference in Relapsed Hodgkin Lymphoma
Hodgkin lymphoma, which affects about 0.2% of the people in the United States, is often treated using a combination of chemotherapy, radiation therapy, and stem cell transplant. Sometimes these treatments fail to halt the progress of the disease, and in other cases the cancer seems to halt but then...
- How is Multiple Myeloma Diagnosed?
Various tests are conducted for the diagnosis of multiple myeloma since one result of a laboratory test cannot diagnose it alone. A number of factors like the history, complete body check-up, diagnostic test reports and symptoms of the patient are taken into consideration to get a proper diagnosis...
- Promising Results for Hodgkin Patients Using This Therapy
Researcher Dr. Bradford S. Hoppe and his colleagues at the University of Florida College of Medicine have recently found that the addition of proton therapy to first-line chemotherapy regimens may improve outcomes for patients with Hodgkin lymphoma.Lymphoma is classically treated with both...
- The Link Between Melatonin and Lymphoma
There’s always room for improvement when it comes to the experience and outcomes of cancer treatment. Fortunately, scientists are constantly researching new, better ways to do so. Although standard treatment remains mostly the same for now, the medical community is making great strides in...
- 9/11 Ground Zero Worker's Lymphoma Improves with Clinical Trial
When the terrorist attacks occurred in New York on September 11th, 2001, Bart Zagami, a 61-year-old New York State Supreme Court officer, was in his office just a few blocks away from the World Trade Center in lower Manhattan. Days after the 9/11 terrorist attacks, Zagami spent his time at Ground...
- New Diagnostic Tool Approved for Lymphoma
A new diagnostic tool has been approved by the U.S. Food and Drug Administration (FDA) to help researchers identify leukemia and lymphoma cells by using a technique known as flow cytometry. A flow cytometry test for non-Hodgkin’s lymphoma (NHL) can help determine whether normal or abnormal DNA is...
Nearby Providers
- Dr. Brian Lee Mcclune DO1950 CIRCLE OF HOPE DR SALT LAKE CITY UT 84112
- Dr. Elizabeth Mary Prystas M.D.1950 CIRCLE OF HOPE SALT LAKE CITY UT 84112
- Dr. Sumati Virendra Gupta MD1950 CIRCLE OF HOPE SALT LAKE CITY UT 84112
- Dr. Theresa Louise Werner MD1950 Circle Of Hope Dr Salt Lake City UT 84112
- Dr. Neeraj Agarwal MD1950 Circle Of Hope Dr Salt Lake City UT 84112
- Dr. Anna C Beck MD1950 CIRCLE OF HOPE SALT LAKE CITY UT 84112